Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	363.89	474.85	571.37	570.88	544.22	450.05
Short-Term Investments	-	-	-	-	-	130
Trading Asset Securities	55.34	22.95	51.5	59.91	98	-
Cash & Short-Term Investments	419.22	497.79	622.87	630.79	642.22	580.05
Cash Growth	-33.45%	-20.08%	-1.26%	-1.78%	10.72%	142.08%
Accounts Receivable	912	932.12	682.86	432.82	312.8	288.77
Other Receivables	6.21	7.1	3.32	2.18	51.41	0.86
Receivables	918.21	939.22	686.18	435.01	364.21	289.63
Inventory	347.64	320.72	175.72	98.08	88.57	47.51
Other Current Assets	41.37	40.25	8.69	8.18	4.55	2.83
Total Current Assets	1,726	1,798	1,493	1,172	1,100	920.01
Property, Plant & Equipment	580.58	585.15	615.13	237.4	157.91	154.36
Long-Term Investments	55.47	22.55	10.08	129.77	119.13	167.82
Goodwill	554.61	554.61	554.61	161.66	-	-
Other Intangible Assets	211.36	216.13	235.23	107.3	20.38	11.84
Long-Term Deferred Tax Assets	15.36	15.13	11.08	6.89	5.12	4.76
Long-Term Deferred Charges	0.56	0.56	0.86	1.54	2.9	-
Total Assets	3,144	3,192	2,920	1,817	1,405	1,259
Accounts Payable	315.17	360.62	247.98	165.26	98.84	35.38
Accrued Expenses	11.22	22.65	39.48	31.33	16.59	12.58
Short-Term Debt	486.56	351.52	255.32	205	200	200
Current Portion of Long-Term Debt	45.27	45.65	45.22	-	-	-
Current Portion of Leases	-	-	0.15	0.5	-	-
Current Income Taxes Payable	29.11	72.64	12.77	10.91	9.4	7.61
Current Unearned Revenue	7.72	7.79	8.17	78.96	5.83	5.89
Other Current Liabilities	247.39	373.58	229.92	56.72	29.76	2.45
Total Current Liabilities	1,142	1,234	839.01	548.68	360.42	263.91
Long-Term Debt	209.3	209.3	254.15	-	-	-
Long-Term Leases	0.4	0.21	0.17	0.17	-	-
Long-Term Unearned Revenue	41.95	42.97	35.97	12.5	12.5	13
Long-Term Deferred Tax Liabilities	24.64	25.5	28.88	6.94	-	-
Other Long-Term Liabilities	84.78	85.04	52.92	10.1	-	-
Total Liabilities	1,504	1,597	1,211	578.4	372.93	276.91
Common Stock	409.8	409.8	409.86	410.86	410.86	407.32
Additional Paid-In Capital	152.59	149.04	225.12	229.69	223.39	201.27
Retained Earnings	1,111	1,069	876.75	625.04	423.75	373.3
Treasury Stock	-100.64	-100.64	-41.43	-26.55	-26.55	-
Total Common Equity	1,573	1,527	1,470	1,239	1,031	981.89
Minority Interest	68.03	67.29	239.04	-0.82	0.61	-0.02
Shareholders' Equity	1,641	1,595	1,709	1,238	1,032	981.88
Total Liabilities & Equity	3,144	3,192	2,920	1,817	1,405	1,259
Total Debt	741.53	606.68	555.02	205.67	200	200
Net Cash (Debt)	-322.31	-108.89	67.86	425.12	442.22	380.05
Net Cash Growth	-	-	-84.04%	-3.87%	16.36%	58.61%
Net Cash Per Share	-0.78	-0.27	0.16	1.03	1.07	0.97
Filing Date Shares Outstanding	419.47	396.85	408.25	410.86	410.86	407.32
Total Common Shares Outstanding	419.47	396.85	408.25	410.86	410.86	407.32
Working Capital	584	563.53	654.46	623.38	739.12	656.1
Book Value Per Share	3.75	3.85	3.60	3.02	2.51	2.41
Tangible Book Value	806.87	756.61	680.48	970.09	1,011	970.05
Tangible Book Value Per Share	1.92	1.91	1.67	2.36	2.46	2.38
Buildings	-	-	549.09	181.14	152.85	152.85
Machinery	-	-	344.91	103.27	58.44	48.76
Construction In Progress	-	-	0.04	48.59	4.17	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.